(Q42873491)

9 November 2017

title

Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters (English)

1 reference

9 November 2017

Yasutaka Maeda

1

1 reference

9 November 2017

Toyoshi Inoguchi

2

1 reference

9 November 2017

Ryoko Takei

3

1 reference

9 November 2017

Fumi Sawada

4

1 reference

9 November 2017

Shuji Sasaki

5

1 reference

9 November 2017

Masakazu Fujii

6

1 reference

9 November 2017

Kunihisa Kobayashi

7

1 reference

9 November 2017

Hidenori Urata

8

1 reference

9 November 2017

Akira Nishiyama

9

1 reference

9 November 2017

Ryoichi Takayanagi

10

1 reference

9 November 2017

publication date

29 September 2010

1 reference

American Journal of Physiology - Renal Physiology

9 November 2017

published in

1 reference

9 November 2017

volume

299

1 reference

9 November 2017

issue

6

1 reference

9 November 2017

page(s)

F1328-38

1 reference

Role of oxidative stress in development of complications in diabetes

9 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Vascular chymase: pathophysiological role and therapeutic potential of inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Identification of renox, an NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Aliskiren: the first renin inhibitor for clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Cinnamophilin reduces oxidative damage and protects against transient focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Free radicals and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Mast cells and type VIII collagen in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

A novel superoxide-producing NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

A new method for large scale isolation of kidney glomeruli from mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Activation of the renin-angiotensin system within podocytes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00337.2010

10.1152/AJPRENAL.00337.2010

21 January 2018

Identifiers

DOI

1 reference

9 November 2017

1 reference